Report cover image

Molecular Diagnostics Market Growth, Size, Trends Analysis - By Product, By Test Location, By Technology, By Application - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Publisher SPER Market Research Pvt. Ltd.
Published Jan 09, 2025
Length 261 Pages
SKU # SPER19520457

Description

Molecular Diagnostics Market Growth, Size, Trends Analysis - By Product, By Test Location, By Technology, By Application - Regional Outlook, Competitive Strategies and Segment Forecast to 2034


Molecular Diagnostics Market Introduction and Overview

According to SPER market research, ‘Global Molecular Diagnostics Market Size- By Product, By Test Location, By Technology, By Application – Regional Outlook, Competitive Strategies and Segment Forecast to 2033’ state that the Global Molecular Diagnostics Market is predicted to reach 39.08 billion by 2034 with a CAGR of 4.26%.

Molecular diagnostics is the identification of genetic variants with the aim of simplifying diagnosis, prognosis, subclassification, and monitoring of therapeutic response. It is a group of techniques for using molecular biology in medical diagnostics that look at biological markers in the proteome and genome as well as the way that genes are expressed by cells as proteins.

Restraints: The high cost of molecular diagnostic technologies is a significant barrier to their market expansion. This equipment is usually only accessible to small labs, clinics, and practitioners with limited funds due to their expensive cost. The need for a large financial investment, particularly for smaller enterprises, restricts the purchase of these devices. This cost barrier prevents molecular diagnostic technology from being widely used in many healthcare settings.

Scope of the Report:

Report Metric Details
Market size available for years 2021-2034
Base year considered 2024
Forecast period 2025-2034
Segments covered By Product, By Test Location, By Technology, By Application.

Regions covered

North America, Asia-Pacific, Latin America, Middle East & Africa and Europe.

Companies Covered

Abbott, Agilent Technologies, Inc., BD, Bio-Rad Laboratories, Inc., BIOMÉRIEUX, Danaher, F. Hoffmann-La Roche, Ltd., Grifols, Hologic Inc. (Gen Probe), Illumina, Inc., QIAGEN, Siemens Healthineers AG, Sysmex Corporation, Others.

Molecular Diagnostics Market Segmentation:

By Product: Based on the Product, Global Molecular Diagnostics Market is segmented as; Instruments, Regards, Others.

By Test Location: Based on the Test Location, Global Molecular Diagnostics Market is segmented as; Point of care, Self-test or OTC, Central laboratories.

By Technology: Based on the Technology, Global Molecular Diagnostics Market is segmented as; Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next-Generation Sequencing, In Situ Hybridization, DNA Microarrays, Other.

By Test-type: Based on the Test-type, Global Molecular Diagnostics Market is segmented as; Lateral Flow Immunoassay, Nucleic Acid Lateral Flow Assay.

By Application: Based on the Application, Global Molecular Diagnostics Market is segmented as; Oncology, Pharmacogenomics, Infectious disease, Genetic Testing, Neurological disease, Cardiovascular disease, Microbiology, Others.

Table of Contents

261 Pages
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPERs internal database
2.1.4. Premium insight from KOLs
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTERs Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Molecular Diagnostics Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Molecular Diagnostics Market
7. Global Molecular Diagnostics Market, By Product (USD Million) 2021-2034
7.1. Instruments
7.2. Regards
7.3. Others
8. Global Molecular Diagnostics Market, By Test Location (USD Million) 2021-2034
8.1. Point of care
8.2. Self-test or OTC
8.3. Central laboratories
9. Global Molecular Diagnostics Market, By Technology (USD Million) 2021-2034
9.1. Polymerase Chain Reaction
9.2. Isothermal Nucleic Acid Amplification Technology
9.3. DNA Sequencing & Next-Generation Sequencing
9.4. In Situ Hybridization
9.5. DNA Microarrays
9.6. Other
10. Global Molecular Diagnostics Market, By Application (USD Million) 2021-2034
10.1. Oncology
10.1.1. Breast Cancer
10.1.2. Prostate Cancer
10.1.3. Colorectal Cancer
10.1.4. Cervical
10.1.5. Kidney
10.1.6. Liver
10.1.7. Blood
10.1.8. Lung
10.1.9. Other
10.2. Pharmacogenomics
10.3. Infectious disease
10.3.1. MRSA
10.3.2. Clostridium difficile
10.3.3. Vancomycin-resistant enterococci
10.3.4. Carbapenem-resistant bacteria testing
10.3.5. Flu
10.3.6. Respiratory syncytial virus (RSV)
10.3.7. Candida
10.3.8. Tuberculosis and drug-resistant TB
10.3.9. Meningitis
10.3.10. Gastro-intestinal panel testing
10.3.11. Chlamydia
10.3.12. Gonorrhea
10.3.13. HIV
10.3.14. Hepatitis C
10.3.15. Hepatitis B
10.3.16. Other Infectious Diseases
10.4. Genetic Testing
10.4.1. Newborn screening
10.4.2. Predictive and presymptomatic testing
10.4.3. Others
10.5. Neurological disease
10.6. Cardiovascular disease
10.7. Microbiology
10.8. Others
11. Global Molecular Diagnostics Market (USD Million) 2021-2034
11.1. Global Molecular Diagnostics Market Size and Market Share
12. Global Molecular Diagnostics Market, By Region (USD Million) 2021-2034
12.1. Asia-Pacific
12.1.1. Australia
12.1.2. China
12.1.3. India
12.1.4. Japan
12.1.5. South Korea
12.1.6. Rest of Asia-Pacific
12.2. Europe
12.2.1. France
12.2.2. Germany
12.2.3. Italy
12.2.4. Spain
12.2.5. United Kingdom
12.2.6. Rest of Europe
12.3. Middle East and Africa
12.3.1. Kingdom of Saudi Arabia
12.3.2. United Arab Emirates
12.3.3. Qatar
12.3.4. South Africa
12.3.5. Egypt
12.3.6. Morocco
12.3.7. Nigeria
12.3.8. Rest of Middle-East and Africa
12.4. North America
12.4.1. Canada
12.4.2. Mexico
12.4.3. United States
12.5. Latin America
12.5.1. Argentina
12.5.2. Brazil
12.5.3. Rest of Latin America
13. Company Profile
13.1. Abbott
13.1.1. Company details
13.1.2. Financial outlook
13.1.3. Product summary
13.1.4. Recent developments
13.2. Agilent Technologies, Inc.
13.2.1. Company details
13.2.2. Financial outlook
13.2.3. Product summary
13.2.4. Recent developments
13.3. BD
13.3.1. Company details
13.3.2. Financial outlook
13.3.3. Product summary
13.3.4. Recent developments
13.4. Bio-Rad Laboratories, Inc.
13.4.1. Company details
13.4.2. Financial outlook
13.4.3. Product summary
13.4.4. Recent developments
13.5. BIOMÉRIEUX
13.5.1. Company details
13.5.2. Financial outlook
13.5.3. Product summary
13.5.4. Recent developments
13.6. Danaher
13.6.1. Company details
13.6.2. Financial outlook
13.6.3. Product summary
13.6.4. Recent developments
13.7. F. Hoffmann-La Roche, Ltd.
13.7.1. Company details
13.7.2. Financial outlook
13.7.3. Product summary
13.7.4. Recent developments
13.8. Grifols
13.8.1. Company details
13.8.2. Financial outlook
13.8.3. Product summary
13.8.4. Recent developments
13.9. Hologic Inc. (Gen Probe)
13.9.1. Company details
13.9.2. Financial outlook
13.9.3. Product summary
13.9.4. Recent developments
13.10. Illumina, Inc.
13.10.1. Company details
13.10.2. Financial outlook
13.10.3. Product summary
13.10.4. Recent developments
13.11. QIAGEN
13.11.1. Company details
13.11.2. Financial outlook
13.11.3. Product summary
13.11.4. Recent developments
13.12. Siemens Healthineers AG
13.12.1. Company details
13.12.2. Financial outlook
13.12.3. Product summary
13.12.4. Recent developments
13.13. Sysmex Corporation
13.13.1. Company details
13.13.2. Financial outlook
13.13.3. Product summary
13.13.4. Recent developments
13.14. Others
14. Conclusion
15. List of Abbreviations
16. Reference Links

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us